182 related articles for article (PubMed ID: 15940288)
1. Case study: management of lymph node-positive disease detected at radical prostatectomy.
Kirby R
Prostate Cancer Prostatic Dis; 2005; 8(3):287-9. PubMed ID: 15940288
[No Abstract] [Full Text] [Related]
2. Case study: management of advanced prostate cancer with soft tissue metastases.
Kirby R
Prostate Cancer Prostatic Dis; 2005; 8(3):290-2. PubMed ID: 15940287
[No Abstract] [Full Text] [Related]
3. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
4. [Reevaluation of MAB therapy and progress of endocrine therapy].
Klotz L; Payne H; Gillatt D; Keane T; Morris C; Akaza H; Hirao ; Akakura K; Fukagai T
Gan To Kagaku Ryoho; 2005 May; 32(5):705-28. PubMed ID: 15934164
[No Abstract] [Full Text] [Related]
5. Radical prostatectomy for clinical stage T3a disease.
Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
[TBL] [Abstract][Full Text] [Related]
6. [Locally advanced prostate cancer: definition, prognosis and treatment].
Plantade A; Massard C; de Crevoisier R; Fizazi K
Bull Cancer; 2007 Jul; 94(7 Suppl):F50-61. PubMed ID: 17845994
[TBL] [Abstract][Full Text] [Related]
7. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
Maffezzini M
J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
[No Abstract] [Full Text] [Related]
8. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.
Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML
J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine differentiation of localized prostate cancer during endocrine therapy.
Nemoto K; Tomita Y
Scand J Urol Nephrol; 2007; 41(6):558-60. PubMed ID: 17853028
[TBL] [Abstract][Full Text] [Related]
10. Prostate carcinoma metastatic to the cervical lymph nodes: report of two cases and review of the literature.
Copeland B; Clark JM; Sura A; Kilpatrick SE; Shockley W; Meredith S
Am J Otolaryngol; 2001; 22(6):420-3. PubMed ID: 11713729
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
Weckermann D; Dorn R; Trefz M; Wagner T; Wawroschek F; Harzmann R
J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
[TBL] [Abstract][Full Text] [Related]
12. Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?
Schumacher MC; Burkhard FC; Thalmann GN; Fleischmann A; Studer UE
Eur Urol; 2006 Aug; 50(2):272-9. PubMed ID: 16632187
[TBL] [Abstract][Full Text] [Related]
13. Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?
Van Poppel H
Eur Urol; 2009 May; 55(5):1012-3. PubMed ID: 19261377
[No Abstract] [Full Text] [Related]
14. Prostate carcinoma I: prognostic factors in radical prostatectomy specimens and pelvic lymph nodes.
Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Mikuz G
BJU Int; 2006 Mar; 97(3):485-91. PubMed ID: 16469013
[No Abstract] [Full Text] [Related]
15. Prognosis of mucinous adenocarcinoma of the prostate treated by radical prostatectomy: a study of 47 cases.
Osunkoya AO; Nielsen ME; Epstein JI
Am J Surg Pathol; 2008 Mar; 32(3):468-72. PubMed ID: 18300802
[TBL] [Abstract][Full Text] [Related]
16. Impact of patient age on biochemical recurrence rates following radical prostatectomy.
Magheli A; Rais-Bahrami S; Humphreys EB; Peck HJ; Trock BJ; Gonzalgo ML
J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in lymph node-positive prostate cancer.
Hofer MD; Kuefer R; Huang W; Li H; Bismar TA; Perner S; Hautmann RE; Sanda MG; Gschwend JE; Rubin MA
Urology; 2006 May; 67(5):1016-21. PubMed ID: 16698361
[TBL] [Abstract][Full Text] [Related]
18. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
[TBL] [Abstract][Full Text] [Related]
19. [Radical prostatectomy--experience with 50 patients].
Goldwasser B; Mor Y; Nativ O; Leibovitch I
Harefuah; 1992 Dec; 123(12):509-12, 572. PubMed ID: 1289194
[TBL] [Abstract][Full Text] [Related]
20. Difficult diagnostic and therapeutic cases: CASE 3. presentation of prostate cancer with cervical adenopathy.
Gaur S; Aish LS; Oo TH
J Clin Oncol; 2004 Mar; 22(5):957-8. PubMed ID: 14990654
[No Abstract] [Full Text] [Related]
[Next] [New Search]
